TIL earnings date and last-quarter result: next report 2026-08-12, last quarter in line, P/E -1.02. Updated 2026-07-23.
Instil Bio (TIL) Research Hub
Instil Bio (TIL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 5.57 USD (-4.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.02, market cap 0.05B. This hub links to the full technical, earnings and options research available for TIL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.57 USD (-4.62%) |
| 52-week range | 5.57 USD – 8.08 USD |
| Trend regime | Range |
| 14-day RSI | 25 (Oversold) |
| Trailing P/E | -1.02 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for TIL
Covered Call on TIL: how it works, illustrative setup around the real 5.57 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TIL: how it works, illustrative setup around the real 5.57 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TIL: how it works, illustrative setup around the real 5.57 USD price, max profit/loss, breakeven and when to use it. Educational.
TIL technical analysis: range, last 5.57 USD, RSI 25, 52w range 5.57 USD–8.08 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TIL in?
Instil Bio (TIL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TIL in an uptrend or downtrend?
As of 2026-10-26, TIL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TIL's trailing P/E ratio?
TIL's trailing P/E is -1.02, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does TIL next report earnings?
TIL is next scheduled to report earnings on 2026-08-12.